Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Sponsor
Eastern Cooperative Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00003027
Collaborator
National Cancer Institute (NCI) (NIH), Southwest Oncology Group (Other), Cancer and Leukemia Group B (Other)
482
94
5.1

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Interferon alfa may interfere with the growth of tumor cells. It is not yet known whether combination chemotherapy plus interleukin-2 and interferon alfa is more effective than combination chemotherapy alone for metastatic melanoma.

PURPOSE: Randomized phase III trial to compare combination chemotherapy with or without interleukin-2 and interferon alfa in treating patients who have metastatic melanoma that cannot be treated by surgery.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

OBJECTIVES:
  • Compare response rate, duration of response, and survival rate in patients with metastatic malignant melanoma treated with cisplatin, vinblastine, and dacarbazine with or without interleukin-2 and interferon alfa-2b.

  • Determine the toxic effects of these regimens in this patient population.

OUTLINE: This is a randomized study. Patients are stratified according to performance status (0 vs 1), prior interferon (yes vs no), and number of involved sites. Patients are randomized to one of two treatment arms.

  • Arm I: Patients receive cisplatin IV over 30 minutes daily immediately followed by vinblastine IV on days 1-4. Patients also receive dacarbazine IV over 60 minutes on day 1 following vinblastine.

  • Arm II: Patients receive treatment as in arm I. Patients also receive interleukin 2 (IL-2) IV continuously on days 1-4 and interferon alfa-2b subcutaneously (SC) daily before IL-2 on days 1-4 and after IL-2 on day 5, followed by filgrastim (G-CSF) (SC) daily on days 7-16.

Treatment repeats every 3 weeks for 4 courses in the absence of disease progression or unacceptable toxicity.

Patients are followed at 6 weeks, every 3 months for 18 months, every 6 months for 18 months, and then annually for 2 years.

PROJECTED ACCRUAL: A total of 482 patients will be accrued for this study within 3.5 years.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
482 participants
Allocation:
Randomized
Primary Purpose:
Treatment
Official Title:
A Randomized Phase III Trial of Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, IL-2 and Interferon A-2B Versus Cisplatin, Vinblastine, Dacarbazine Alone in Patients With Metastatic Malignant Melanoma
Study Start Date :
Oct 1, 1997
Actual Primary Completion Date :
Jul 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Overall survival []

Secondary Outcome Measures

  1. Response rate (complete and partial response) []

  2. Durable complete response rate []

  3. Response duration []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Histologically confirmed surgically incurable metastatic malignant melanoma

  • Measurable disease

  • No active brain metastases or edema

  • No leptomeningeal disease

  • No ocular melanoma

PATIENT CHARACTERISTICS:
Age:
  • 18 and over
Performance status:
  • ECOG 0-1
Life expectancy:
  • Not specified
Hematopoietic:
  • Absolute neutrophil count at least 1,500/mm^3

  • Platelet count at least 100,000/mm^3

  • Hemoglobin at least 9 g/dL

Hepatic:
  • Bilirubin no greater than 1.5 mg/dL

  • SGOT less than 3 times the upper limit of normal unless due to liver metastases

Renal:
  • Creatinine less than 1.5 mg/dL OR

  • Creatinine clearance at least 75 mL/min

Cardiovascular:
  • No congestive heart failure

  • No symptoms of coronary artery disease

  • No serious cardiac arrhythmias

  • No prior myocardial infarction on EKG

  • Normal cardiac stress test required for the following:

  • Over 50 years of age

  • Abnormal EKG

  • Prior history of cardiac disease

Pulmonary:
  • No symptomatic pulmonary disease

  • FEV1 greater than 2.0 L OR at least 75% predicted if over 50 years of age or with history of pulmonary symptoms

Other:
  • Not pregnant or nursing

  • Negative pregnancy test

  • Fertile patients must use effective contraception

  • No significant infection

  • HIV negative

  • No other prior malignancy within the past 5 years except basal cell or squamous cell skin cancer or carcinoma in situ of the cervix

  • No organ allografts

  • No significant disease other than malignancy

  • No seizure disorder

PRIOR CONCURRENT THERAPY:
Biologic therapy:
  • No prior interleukin-2 therapy for metastatic disease

  • At least 4 weeks since prior vaccine therapy

  • At least 4 weeks since prior adjuvant immunotherapy

Chemotherapy:
  • No prior chemotherapy for disease
Endocrine therapy:
  • No concurrent corticosteroids
Radiotherapy:
  • No prior radiation therapy to measurable disease site unless disease is clearly progressive

  • At least 4 weeks since prior radiation therapy for local control or palliation and recovered

Surgery:
  • Recovered from prior surgery
Other:
  • No prior systemic therapy for metastatic disease

  • At least 3 months since definitive therapy for brain metastases

Contacts and Locations

Locations

Site City State Country Postal Code
1 MBCCOP - Gulf Coast Mobile Alabama United States 36688
2 CCOP - Greater Phoenix Phoenix Arizona United States 85006-2726
3 Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix Arizona United States 85012
4 Veterans Affairs Medical Center - Tucson Tucson Arizona United States 85723
5 Arizona Cancer Center Tucson Arizona United States 85724
6 University of Arkansas for Medical Sciences Little Rock Arkansas United States 72205
7 Veterans Affairs Medical Center - Little Rock (McClellan) Little Rock Arkansas United States 72205
8 Cancer Center and Beckman Research Institute, City of Hope Duarte California United States 91010-3000
9 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California United States 90033-0804
10 Veterans Affairs Medical Center - West Los Angeles Los Angeles California United States 90073
11 Jonsson Comprehensive Cancer Center, UCLA Los Angeles California United States 90095-1781
12 Veterans Affairs Outpatient Clinic - Martinez Martinez California United States 94553
13 CCOP - Bay Area Tumor Institute Oakland California United States 94609-3305
14 Chao Family Comprehensive Cancer Center Orange California United States 92868
15 University of California Davis Medical Center Sacramento California United States 95817
16 UCSF Cancer Center and Cancer Research Institute San Francisco California United States 94143-0128
17 CCOP - Santa Rosa Memorial Hospital Santa Rosa California United States 95403
18 David Grant Medical Center Travis Air Force Base California United States 94535
19 University of Colorado Cancer Center Denver Colorado United States 80010
20 Veterans Affairs Medical Center - Denver Denver Colorado United States 80220
21 CCOP - Atlanta Regional Atlanta Georgia United States 30342-1701
22 Dwight David Eisenhower Army Medical Center Fort Gordon Georgia United States 30905-5650
23 Cancer Research Center of Hawaii Honolulu Hawaii United States 96813-2424
24 MBCCOP - University of Illinois at Chicago Chicago Illinois United States 60612-7323
25 Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois United States 60612
26 CCOP - Central Illinois Decatur Illinois United States 62526
27 Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois United States 60141
28 Loyola University Medical Center Maywood Illinois United States 60153
29 University of Kansas Medical Center Kansas City Kansas United States 66160-7353
30 CCOP - Wichita Wichita Kansas United States 67214-3882
31 Veterans Affairs Medical Center - Wichita Wichita Kansas United States 67218
32 Veterans Affairs Medical Center - Lexington Lexington Kentucky United States 40502-2236
33 Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky United States 40536-0084
34 MBCCOP - LSU Health Sciences Center New Orleans Louisiana United States 70112
35 Tulane University School of Medicine New Orleans Louisiana United States 70112
36 Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana United States 71130-3932
37 Veterans Affairs Medical Center - Shreveport Shreveport Louisiana United States 71130
38 Boston Medical Center Boston Massachusetts United States 02118
39 Veterans Affairs Medical Center - Boston (Jamaica Plain) Jamaica Plain Massachusetts United States 02130
40 Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan United States 48105
41 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
42 University of Michigan Comprehensive Cancer Center Ann Arbor Michigan United States 48109-0912
43 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201-1379
44 Veterans Affairs Medical Center - Detroit Detroit Michigan United States 48201-1932
45 Henry Ford Hospital Detroit Michigan United States 48202
46 Providence Hospital - Southfield Southfield Michigan United States 48075-9975
47 CCOP - Duluth Duluth Minnesota United States 55805
48 Veterans Affairs Medical Center - Biloxi Biloxi Mississippi United States 39531-2410
49 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
50 Veterans Affairs Medical Center - Jackson Jackson Mississippi United States 39216
51 Keesler Medical Center - Keesler AFB Keesler AFB Mississippi United States 39534-2576
52 Veterans Affairs Medical Center - Kansas City Kansas City Missouri United States 64128
53 CCOP - Kansas City Kansas City Missouri United States 64131
54 St. Louis University Health Sciences Center Saint Louis Missouri United States 63110
55 CCOP - St. Louis-Cape Girardeau Saint Louis Missouri United States 63141
56 CCOP - Cancer Research for the Ozarks Springfield Missouri United States 65807
57 CCOP - Montana Cancer Consortium Billings Montana United States 59101
58 Veterans Affairs Medical Center - Albuquerque Albuquerque New Mexico United States 87108-5138
59 MBCCOP - University of New Mexico HSC Albuquerque New Mexico United States 87131
60 Veterans Affairs Medical Center - Albany Albany New York United States 12208
61 Herbert Irving Comprehensive Cancer Center New York New York United States 10032
62 University of Rochester Medical Center Rochester New York United States 14642
63 CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina United States 27104-4241
64 Veterans Affairs Medical Center - Cincinnati Cincinnati Ohio United States 45220-2288
65 Barrett Cancer Center, The University Hospital Cincinnati Ohio United States 45267-0501
66 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195
67 CCOP - Columbus Columbus Ohio United States 43206
68 Veterans Affairs Medical Center - Dayton Dayton Ohio United States 45428
69 CCOP - Dayton Kettering Ohio United States 45429
70 CCOP - Toledo Community Hospital Oncology Program Toledo Ohio United States 43623-3456
71 Oklahoma Medical Research Foundation Oklahoma City Oklahoma United States 73104
72 Veterans Affairs Medical Center - Oklahoma City Oklahoma City Oklahoma United States 73104
73 Veterans Affairs Medical Center - Portland Portland Oregon United States 97207
74 CCOP - Columbia River Program Portland Oregon United States 97225
75 OHSU Cancer Institute Portland Oregon United States 97239
76 Veterans Affairs Medical Center - Charleston Charleston South Carolina United States 29401-5799
77 Medical University of South Carolina Charleston South Carolina United States 29425-0721
78 CCOP - Greenville Greenville South Carolina United States 29615
79 CCOP - Upstate Carolina Spartanburg South Carolina United States 29303
80 Simmons Cancer Center - Dallas Dallas Texas United States 75235-8852
81 Brooke Army Medical Center Fort Sam Houston Texas United States 78234-6200
82 University of Texas Medical Branch Galveston Texas United States 77555-0565
83 Veterans Affairs Medical Center - Houston Houston Texas United States 77030
84 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78284-7845
85 Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas United States 78284
86 Veterans Affairs Medical Center - Temple Temple Texas United States 76504
87 CCOP - Scott and White Hospital Temple Texas United States 76508
88 Huntsman Cancer Institute Salt Lake City Utah United States 84112-5550
89 Veterans Affairs Medical Center - Salt Lake City Salt Lake City Utah United States 84148
90 CCOP - Virginia Mason Research Center Seattle Washington United States 98101
91 Swedish Cancer Institute Seattle Washington United States 98104
92 Veterans Affairs Medical Center - Seattle Seattle Washington United States 98108
93 CCOP - Northwest Tacoma Washington United States 98405-0986
94 Madigan Army Medical Center Tacoma Washington United States 98431-5048

Sponsors and Collaborators

  • Eastern Cooperative Oncology Group
  • National Cancer Institute (NCI)
  • Southwest Oncology Group
  • Cancer and Leukemia Group B

Investigators

  • Study Chair: Michael B. Atkins, MD, Tufts Medical Center
  • Study Chair: Lawrence E. Flaherty, MD, Barbara Ann Karmanos Cancer Institute
  • Study Chair: David M. Gustin, MD, University of Illinois at Chicago

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00003027
Other Study ID Numbers:
  • CDR0000065617
  • E3695
  • CLB-509802
  • SWOG-E3695
First Posted:
Jan 27, 2003
Last Update Posted:
Jan 29, 2010
Last Verified:
Jan 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2010